Notice

MAVIS edition 102

Marketing Authorisations Veterinary Information Service (MAVIS) edition 102

• From: Veterinary Medicines Directorate
• Published: 26 April 2017

Documents

MAVIS edition 102

HTML

Details

Content of MAVIS 102:

• Pharmaceutical Industry Information Event on 23 June 2017
• Restrictions on Schedule 6 (Exemptions for small pet animals) active substances
• Guidance for applicants regarding applications to be submitted under Article 13
• Marketing Authorisations
• Quarterly reporting against VMD Published Standards for 2016-17 licensing work
• Top Ten Imported Veterinary Medicines Quarterly Report from 1 January to 31 March 2017
• Good Manufacturing Practice Inspection Team (GMPIT)
• GMPIT inspection deficiency classification
• GMPIT inspection deficiency findings 1 April 2016 to 31 March 2017
• The Inspections and Investigations Team (IIT)
• Changes to Wholesale Dealer Authorisation (WDA) application and variation forms
• Pharmacovigilance quarterly report
• Enforcement
• Antimicrobial Resistance
• Veterinary Products Committee
• Residues controls and monitoring
• Staff changes
• VMD organogram as at 1 April 2017

Published 26 April 2017